211 related articles for article (PubMed ID: 32807587)
1. COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China.
Ranard LS; Parikh SA; Kirtane AJ
J Am Coll Cardiol; 2020 Sep; 76(11):1325-1327. PubMed ID: 32807587
[TBL] [Abstract][Full Text] [Related]
2. Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report.
Xuan TM; Wang XX; Pu XY; Han WL; Guo XG
J Zhejiang Univ Sci B; 2020 May; 21(5):411-415. PubMed ID: 32425009
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
[TBL] [Abstract][Full Text] [Related]
4. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
[No Abstract] [Full Text] [Related]
5. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Bainey KR; Bates ER; Armstrong PW
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
[No Abstract] [Full Text] [Related]
6. Delay, Death, and Heterogeneity of Primary PCI During the COVID-19 Pandemic: An International Perspective.
Park DW; Yang Y
J Am Coll Cardiol; 2020 Nov; 76(20):2331-2333. PubMed ID: 33183507
[TBL] [Abstract][Full Text] [Related]
7. Standards of Care in Crisis: ST-Segment-Elevation Myocardial Infarction Management in COVID-19.
Mihatov N; Kirtane AJ
Circ Cardiovasc Interv; 2020 Nov; 13(11):e010143. PubMed ID: 33167704
[No Abstract] [Full Text] [Related]
8. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane AJ; Bangalore S
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
[No Abstract] [Full Text] [Related]
9. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
[No Abstract] [Full Text] [Related]
10. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
Lotfi AS; Capatina A; Kugelmass AD
Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
[No Abstract] [Full Text] [Related]
11. The Unbearable Thrombus of COVID-19: Primary PCI, Thrombus, and COVID-19.
Dauerman HL
J Am Coll Cardiol; 2020 Sep; 76(10):1177-1180. PubMed ID: 32883410
[TBL] [Abstract][Full Text] [Related]
12. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
Li YH; Huang WC; Hwang JJ;
Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
[No Abstract] [Full Text] [Related]
13. COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
De Filippo O; D'Ascenzo F; Deferrari GM
Heart; 2020 Dec; 106(23):1786-1787. PubMed ID: 33087411
[No Abstract] [Full Text] [Related]
14. Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19.
Kurdi H; Obaid DR; UlHaq Z; Ionescu A; Sekar B
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-6. PubMed ID: 32730159
[No Abstract] [Full Text] [Related]
15. Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.
Nan J; Meng S; Hu H; Jia R; Chen W; Li Q; Zhang T; Song K; Wang Y; Jin Z
Med Sci Monit; 2020 Sep; 26():e927061. PubMed ID: 32938901
[TBL] [Abstract][Full Text] [Related]
16. Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.
Butala NM; Patel NK; Chhatwal J; Vahdat V; Pomerantsev EV; Albaghdadi M; Sakhuja R; Rosenzweig A; Elmariah S
Circ Cardiovasc Interv; 2020 Nov; 13(11):e010027. PubMed ID: 33167699
[TBL] [Abstract][Full Text] [Related]
17. Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria.
Kiblboeck D; Kellermair J; Siostrzonek P; Steinwender C
Wien Klin Wochenschr; 2020 Jul; 132(13-14):362-364. PubMed ID: 32533442
[No Abstract] [Full Text] [Related]
18. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19.
Setia G; Tyler J; Kwan A; Faguet J; Sharma S; Singh S; Azarbal B; Tompkins R; Chinchilla D; Ghandehari S
Rev Cardiovasc Med; 2020 Jun; 21(2):289-295. PubMed ID: 32706216
[TBL] [Abstract][Full Text] [Related]
19. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
Choudry FA; Hamshere SM; Rathod KS; Akhtar MM; Archbold RA; Guttmann OP; Woldman S; Jain AK; Knight CJ; Baumbach A; Mathur A; Jones DA
J Am Coll Cardiol; 2020 Sep; 76(10):1168-1176. PubMed ID: 32679155
[TBL] [Abstract][Full Text] [Related]
20. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Sudhakar D; Jneid H; Lakkis N; Kayani WT
Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
